Professional GMP & Biosafety Compliant Full-Service Engineering for mRNA Vaccine Production Plants
Our mRNA vaccine manufacturing facility design and engineering delivers customized end-to-end turnkey solutions dedicated to the construction of modern mRNA biotech production workshops, pilot labs and commercial-scale manufacturing sites. We cover the whole technical workflow including plasmid DNA production, in-vitro transcription, mRNA purification, LNP lipid nanoparticle formulation, sterile filling, cold-chain storage and finished vaccine packaging, perfectly matching the ultra-sensitive production characteristics of mRNA therapeutic and vaccine products.
We provide comprehensive full-cycle engineering services, including process-driven factory layout planning, strict one-way man-material flow partition, ISO classified sterile cleanroom construction, independent negative-pressure biosafety suites, dedicated low-temperature HVAC constant temperature control system, WFI & pure steam utility station, closed bioprocess pipeline integration, CIP/SIP automatic cleaning and sterilization system, full-process real-time environmental & process data monitoring platform, biohazard waste gas/liquid treatment system, on-site installation, full factory commissioning, GMP qualification validation, regulatory document compilation and professional operator training. All design standards strictly follow FDA cGMP, EU GMP Annex 1, ICH guidelines and global biological product regulatory requirements to support smooth clinical trial application and commercial registration audit.
Different from traditional vaccine workshops, our engineering design fully addresses the fragility of mRNA molecules, strict RNase-free environment control, ultra-low temperature storage and special LNP preparation safety demands. The whole plant adopts fully enclosed, isolated production zones to avoid RNase contamination and cross-product interference. Low-temperature constant humidity control runs through formulation and filling procedures to protect mRNA activity. Highly automated closed production lines drastically reduce manual exposure risks, ensuring consistent batch quality and high yield of mRNA-LNP finished vaccines. Modular structural design supports flexible capacity expansion from small pilot R&D lines to large-volume mass production factories.
With rich professional experience in advanced nucleic acid biopharmaceutical engineering, we supply tailored solutions for new greenfield plant construction, existing biotech workshop renovation and mRNA production line capacity upgrading. From early technical consultation, risk assessment and drawing design to complete project handover and lifelong after-sales technical support, we effectively shorten project delivery cycles, lower compliance risks and accelerate clients’ mRNA vaccine industrialization progress.
Core Advantages
- Exclusive RNase-free cleanroom design for plasmid and mRNA production workflow
- Constant low-temperature & humidity environment system to preserve mRNA biological activity
- Independent isolation layout to eliminate cross-contamination and RNase pollution risks
- Complete closed LNP formulation, sterile filling and cold-chain supporting system
- Fully compliant with international cGMP and biological vaccine regulatory standards
- Customizable layout for R&D pilot scale and commercial mass production, full validation support & long-term engineering service
